Published
Co-Chairs, Nasser Altorki, MD, and Jonathan D. Spicer, MD, PhD, FRCSC, discuss NSCLC in this CME/MOC activity titled “Can the Addition of Immunotherapy to Multimodal Management of Stage I-III NSCLC Help Break the Stalled Cycle of Poor Outcomes?” For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC information, and to apply for credit, please visit us at PeerView.com/CRA865. CME/MOC credit will be available until February 27, 2023.
- Category
- Management
Be the first to comment
-
1:02:06
Episode 54 – Level up your Career - How to improve PPP Outcomes
-
41:23
Multimodal Management of Early-Stage NSCLC: EGFR-Targeted Therapy in Perioperative Settings
-
22:29
Dr. Kamlesh Khunti - Simplfying Type 2 Diabetes Management to Improve Outcomes
-
2:01:29
Health Affairs Briefing: Type 2 Diabetes: Policies To Improve Prevention, Care And Outcomes
-
1:19:44
Revealing policy barriers in diabetes care: How we can improve outcomes
-
56:39
Know Diabetes by Heart: Team-Based Care Strategies to Improve Patient Outcomes
-
57:52
Accelerating Country-Led Digital Health Transformation for Data Use to Improve Health Outcomes
-
10:07
SIAM Roadmap - Understand the Run & Improve stage
-
1:02:05
Adjuvant EGFR-Targeted Therapy as a Game Changer in Multimodal NSCLC Management
-
1:53:30
Immunotherapy Symposium in Denmark | My Lecture on the state of immunotherapy in oncology
-
03:29
Deca Roleplay Video - Lily Papadakis (Marshall) (Business Management)
-
00:20
motivational video for libasna ll inspiration for upsc aspirants ll #short #upse #amitabhbachchan
-
17:46
FreeStyle Libre 3 vs Dexcom G6 | Full Test & Review
-
09:59
Learn Communication Skills | English Speaking | Management Insight #7
-
1:43:58
How to Trade In Stocks By: Jesse Livermore. Complete Audiobook.
-
06:52
Three Questions to Ask Yourself To Be a Great Leader
-
07:35
find your unique style | Style Roots QUIZ + body types
